The world will need more than one COVID-19 vaccine, says GSK CEO
Emma Walmsley, CEO, GlaxoSmithKline , said GSK's partnership with Sanofi brings scale to the attempt to get a COVID-19 vaccine but…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
GSK
Sanofi and GSK to join forces to develop vaccine for COVID-19
Candidate vaccine expected to enter clinical trials in the second half of 2020 and, if successful, to be available in the second…
Cipla announces completion of phase-3 clinical study for generic version of GSK’s Advair Diskus
The study, completed in the first attempt, was conducted over a period of 15 months at over 100 sites in the US enrolling 1,400…
GSK launches Iodex UltraGel
The launch strengthens GSK’s pain relief portfolio in India making it one of the formidable players in the non-prescription space.…
Signs of progress against the superbugs, but not yet at the scale needed: Study
The 2020 Antimicrobial Resistance Benchmark evaluates how 30 pharmaceutical companies are limiting drug-resistance
GSK credits STEER for Horlicks technology after year long IP Battle
Following the settlement, GSK has issued a public statement acknowledging STEER’s contribution in creating step change technology…
US FDA declines to approve GSK drugs division’s long acting HIV injection
ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in…
Chiron Behring re-launches its rabies vaccine as ‘Chirorab’
Chiron Behring Vaccines was acquired by Bharat Biotech from GSK in March 2019 and commercial operations were restarted in May 2019
After sartans and ranitidine, where will NDMA show up next?
While regulators and pharma companies try to understand if it is the product or the process that is at fault in the ranitidine…
GSK announces tuberculosis vaccine Phase IIb Trial results
The Indian government has made the fight against TB a central priority and boldly pledged to end TB by 2025, five years before the…